Crispina Calsada | CFO |
Joseph Hagan | President & CEO |
Yi Chen | H.C. Wainwright & Co. |
Good morning, and welcome to the Regulus Therapeutics Second Quarter Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator instructions] Please note, this event is being recorded. I would now like to turn the conference over to Cris Calsada, Chief Financial Officer of Regulus.